AGT and Myocardial fibrosis: Inhibition of Hsp90 with an engineered protein inhibitor reduced the TGF-β-mediated profibrotic events in cardiac fibroblasts in vitro and ameliorated experimental murine myocardial fibrosis induced by angiotensin-II [57].